On Biostatistics and Clinical Trials: Serial Blood Sample Timepoints for Comparing Pharmacokinetics Profiles Between Two Different Dose Frequencies
Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives - ScienceDirect
Frontiers | Computational Approaches in Preclinical Studies on Drug Discovery and Development | Chemistry
PK in Late Phase Trials
Database of pharmacokinetic time-series data and parameters for 144 environmental chemicals | Scientific Data
![PDF] Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba643ff4c798a7864e6a78f009413a89e764a2c0/6-Figure2-1.png "PDF] Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist | Semantic Scholar")
PDF] Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist | Semantic Scholar
Should You Include Time Windows for PK/PD Sample Collection?
Pharmaceutics | Free Full-Text | Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as Total | HTML
How to design a study to evaluate therapeutic drug monitoring in infectious diseases? - Clinical Microbiology and Infection
Power estimation using a population pharmacokinetics model with optimal design by clinical trial simulations: application in pharmacokinetic drug– drug interaction studies | Vidho Rivera - Academia.edu
Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies | British Journal of Cancer
a Staggered approach and sampling strategy for collecting PK/PD and... | Download Scientific Diagram
PK Clinical Trial During New Drug Discovery and Development – An Overview by mariabrownema - Issuu
Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades: Trends in Pharmacological Sciences
Modelling and simulation in drug development, promise and reality – Drug Discovery World (DDW)
Frontiers | Tolerability, Safety, Pharmacokinetics and Drug Interaction of Cefotaxime Sodium–Tazobactam Sodium Injection (6:1) Following Single and Multiple Intravenous Doses in Chinese Healthy Subjects | Pharmacology
Application of Pharmacokinetics in Early Drug Development | IntechOpen
What is a PP Population, or 'Per Protocol' Population in a Clinical Trial? - Quantics Biostatistics
Pharmacodynamic Biomarker Testing - Almac
Phase 1 clinical trial schema. Abbreviations: E = enrollment, qwk = per... | Download Scientific Diagram
Impact of Sample Handling and Processing on Bioanalycial Outcome
PK_PD-Sample-Management - Clinical trials and CRO centric systems
CLINICAL TRIAL PROCEDURES THAT ARE PERFORMED IN PATIENTS' HOMEs - WEP Clinical
Dose rationale and pharmacokinetics of dexmedetomidine in mechanically ventilated new-borns: impact of design optimisation | SpringerLink
Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial - The Lancet HIV
Pharmacokinetic and Statistical Considerations in First-in-Human Clinical Trials | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services
